RELIEF THERAPEUTICS Holding SA, formerly known as mondoBIOTECH holding AG, is a Switzerland-based company that focuses on the development of treatments of diabetic complications and respiratory diseases. It specializes in clinical stage project and drugs of natural human origin (peptides and proteins) with a history of clinical testing and use in human patients. Its main products are Aviptadil and Atexakin Alfa. Aviptadil is an abundant biologically active endogenous human peptide acting as a ligand on specific G-protein coupled transmembrane receptors. Atexakin Alfa is a low-dosage formulation of interleukin-6 (IL-6), a cytokine that promotes nerve regeneration and remyelination, and protects neurons from toxic injuries.